LigoCyte Pharmaceuticals' Series C - II Round

LigoCyte Pharmaceuticals raised a round of funding on August 06, 2008.

Ligocyte focuses on cellular immunology and new approaches to fight dangerous pathogens. The company's lead programs include vaccines against norovirus, anthrax and influenza.…

Articles about LigoCyte Pharmaceuticals' Series C - II Round: